Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in Portuguese | Spanish

Search for reporting guidelines

Use your browser's Back button to return to your search results

REporting recommendations for tumour MARKer prognostic studies (REMARK)

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
Tumour marker prognostic studies
Full bibliographic reference McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387-391.
Language English
PubMed ID 16106245
Relevant URLs
(full-text if available)
The reporting checklist for tumour marker prognostic studies is available at: REMARK checklist
Explanation and elaboration papers Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

BMC Med. 2012;10:51. PMID: 22642691
PLoS Med. 9(5):e1001216. Link to full-text
Reporting guideline acronym REMARK
Study design Diagnostic and prognostic studies, Observational studies
Clinical area Genetics, Oncology
Applies to the whole report or to individual sections of the report? Whole report
Record last updated on October 13, 2016


Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.

Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.